You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell NHL

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

Not yet recruiting
  • Non Hodgkin's Lymphoma
  • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
  • +2 more
  • Beijing, China
  • +2 more
Aug 23, 2023

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

Not yet recruiting
  • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
  • (no location specified)
Mar 23, 2023

Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Perth, Western Australia, Australia
    Linear Clinical Research Ltd
Apr 20, 2023

LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 19, 2023

    B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

    Not yet recruiting
    • B-cell Non-Hodgkin Lymphoma
    • +4 more
    • (no location specified)
    Dec 7, 2022

    Relapsed DLBCL, Refractory DLBCL Trial in Hackensack (ABT-199, Ibrutinib, Rituximab)

    Active, not recruiting
    • Relapsed Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Oct 7, 2022

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • UCD19 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

    Not yet recruiting
    • NHL, Relapsed, Adult
    • +3 more
    • KUR-502
    • (no location specified)
    Aug 2, 2022

    Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma, Relapsed
    • +8 more
    • PBCAR20A
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    Severe COVID-19 Infection in CLL or B-NHL Who Received

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
      • (no location specified)
      Apr 6, 2023

      Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)

      Recruiting
      • Non Hodgkin's Lymphoma
      • Allogenic CD19-CAR-γδT cell
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Jan 31, 2023

      Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

      Recruiting
      • Non-hodgkin Lymphoma,B Cell
      • Autologous CD19-STAR-T cell
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2022

      B-cell Non-Hodgkin's Lymphoma Trial in Cincinnati (IMM0306)

      Recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • Cincinnati, Ohio
        The Christ Hospital
      Apr 1, 2022

      B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

      Not yet recruiting
      • B-cell Non-Hodgkins Lymphoma (B-NHL)
      • (no location specified)
      Jan 5, 2023

      B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma (B-NHL)
      • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
      • PIT565
      • (no location specified)
      Jun 13, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      Diffuse Large B Cell Lymphoma (DLBCL) Trial in Denver, Nashville (bbT369)

      Recruiting
      • Diffuse Large B Cell Lymphoma (DLBCL)
      • bbT369
      • Denver, Colorado
      • +1 more
      Feb 10, 2022

      Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

      Active, not recruiting
      • Non-Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • autologous or syngeneic PBTLs and EBV-CTLs
      • Houston, Texas
      • +1 more
      Feb 6, 2022

      B-cell Non Hodgkin Lymphoma Trial in Hangzhou (anti-CD19 CAR-NK)

      Recruiting
      • B-cell Non Hodgkin Lymphoma
      • anti-CD19 CAR-NK
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      May 13, 2021

      Hematoma Trial in Beijing (CM355)

      Active, not recruiting
      • Hematoma
      • Beijing, China
        Beijing university cancer hospital
      Jan 10, 2022

      CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

      Recruiting
      • CAR
      • +2 more
      • ThisCART19A with Dose Level 1
      • ThisCART19A with Dose Level 2
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jan 18, 2023

      Mature B-cell Non-Hodgkin Lymphoma Trial in Chengdu (Prednisone,Vincristine, Cyclophosphamide, Cyclophosphamide, Vincristine,

      Active, not recruiting
      • Mature B-cell Non-Hodgkin Lymphoma
      • Prednisone,Vincristine, Cyclophosphamide
      • +5 more
      • Chengdu, Sichuan, China
        West China Second University Hospital of Sichuan University
      Mar 17, 2022

      Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • (no location specified)
      Aug 23, 2022